Vivani Medical, Inc.
VANI
$1.34
$0.010.91%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -18.39% | 15.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.88% | 13.80% | |||
| Operating Income | 9.88% | -13.80% | |||
| Income Before Tax | 8.59% | -13.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.59% | -13.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.59% | -13.36% | |||
| EBIT | 9.88% | -13.80% | |||
| EBITDA | 10.05% | -14.02% | |||
| EPS Basic | 9.29% | -13.35% | |||
| Normalized Basic EPS | 9.28% | -13.38% | |||
| EPS Diluted | 9.29% | -13.35% | |||
| Normalized Diluted EPS | 9.28% | -13.38% | |||
| Average Basic Shares Outstanding | 0.79% | 0.01% | |||
| Average Diluted Shares Outstanding | 0.79% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||